A cluster-randomized trial showed a mail-in letter campaign increased vaccination uptake from 4% to 35% at 1 year.
Prior influenza vaccination strongly predicted pneumococcal vaccine uptake, indicating patient and clinician engagement is key.
Guideline-Based Recommendations
Diagnosis
Identify patients with chronic heart failure as a high-risk group for pneumococcal disease.
Management
Recommend pneumococcal vaccination for patients with chronic heart failure per established guidelines.
Implement scalable, low-cost interventions such as targeted mail-in campaigns to increase vaccination rates.
Monitoring & Follow-up
Track vaccination uptake using administrative or claims databases to evaluate intervention impact.
Monitor timing of vaccination relative to intervention delivery to optimize effectiveness.
Risks
Be aware of vaccine hesitancy and lack of awareness as barriers to vaccination.
Consider potential performance bias in open-label interventions influencing behavior beyond the intervention itself.
Patient & Prescribing Data
Patients with chronic heart failure identified via national health databases
Mail-in letters targeting both patients and their general practitioners significantly increase pneumococcal vaccination rates; prior influenza vaccination is a strong predictor of uptake.
Clinical Best Practices
Leverage existing healthcare infrastructure and databases to identify eligible patients and deliver interventions.
Engage both patients and clinicians simultaneously to foster shared awareness and prompt vaccination discussions.
Use simple, scalable, and low-cost strategies to improve adherence to vaccination guidelines.
Consider cultural and regional factors that may affect generalizability and acceptance of vaccination programs.
Evaluate downstream clinical outcomes to further support vaccination program benefits.
